<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; mid-cap</title>
	<atom:link href="http://www.tapanray.in/tag/mid-cap/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Global ‘Contract Research and Manufacturing Services’ (CRAMS) – a new growth opportunity for mid-cap Indian pharmaceutical companies&#8230; Are we ready?</title>
		<link>http://www.tapanray.in/global-contract-research-and-manufacturing-services-crams-a-new-growth-opportunity-for-mid-cap-indian-pharmaceutical-companies-are-we-ready/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=global-contract-research-and-manufacturing-services-crams-a-new-growth-opportunity-for-mid-cap-indian-pharmaceutical-companies-are-we-ready</link>
		<comments>http://www.tapanray.in/global-contract-research-and-manufacturing-services-crams-a-new-growth-opportunity-for-mid-cap-indian-pharmaceutical-companies-are-we-ready/#comments</comments>
		<pubDate>Sat, 27 Jun 2009 01:00:20 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[a]]></category>
		<category><![CDATA[and]]></category>
		<category><![CDATA[companies]]></category>
		<category><![CDATA[Contract]]></category>
		<category><![CDATA[CRAMS]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[growth]]></category>
		<category><![CDATA[Indian]]></category>
		<category><![CDATA[manufacturing]]></category>
		<category><![CDATA[mid-cap]]></category>
		<category><![CDATA[New]]></category>
		<category><![CDATA[opportunity]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[research]]></category>
		<category><![CDATA[services]]></category>
		<category><![CDATA[Tapan]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=854</guid>
		<description><![CDATA[Intense competition within global pharmaceutical industry, patent expiries of blockbuster drugs, ballooning R&#38;D costs together with low R&#38;D productivity, more and more stringent regulatory standards coupled with intense cost containment measures are exerting intense pressure on the bottom lines of &#8230; <a href="http://www.tapanray.in/global-contract-research-and-manufacturing-services-crams-a-new-growth-opportunity-for-mid-cap-indian-pharmaceutical-companies-are-we-ready/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/global-contract-research-and-manufacturing-services-crams-a-new-growth-opportunity-for-mid-cap-indian-pharmaceutical-companies-are-we-ready/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
